» Articles » PMID: 35995784

Honghua Extract Mediated Potent Inhibition of COVID-19 Host Cell Pathways

Overview
Journal Sci Rep
Specialty Science
Date 2022 Aug 22
PMID 35995784
Authors
Affiliations
Soon will be listed here.
Abstract

Honghua (Carthami flos) and Xihonghua (Croci stigma) have been used in anti-COVID-19 as Traditional Chinese Medicine, but the mechanism is unclear. In this study, we applied network pharmacology by analysis of active compounds and compound-targets networks, enzyme kinetics assay, signaling pathway analysis and investigated the potential mechanisms of anti-COVID-19. We found that both herbs act on signaling including kinases, response to inflammation and virus. Moreover, crocin likely has an antiviral effect due to its high affinity towards the human ACE2 receptor by simulation. The extract of Honghua and Xihonghua exhibited nanozyme/herbzyme activity of alkaline phosphatase, with distinct fluorescence. Thus, our data suggest the great potential of Honghua in the development of anti-COVID-19 agents.

Citing Articles

Potential Anti-Obesity Effect of Hazel Leaf Extract in Mice and Network Pharmacology of Selected Polyphenols.

Zhao J, Alimu A, Li Y, Lin Z, Li J, Wang X Pharmaceuticals (Basel). 2024; 17(10).

PMID: 39458990 PMC: 11510286. DOI: 10.3390/ph17101349.


The mechanism of Zhenzhu Pills treating intracerebral hemorrhage secondary injury based on network pharmacology and molecular docking.

Wu G, Ren Z, Hao Q, Wong Y, Zha D, Cao X Medicine (Baltimore). 2024; 103(7):e36837.

PMID: 38363944 PMC: 10869077. DOI: 10.1097/MD.0000000000036837.


Berberine alleviates myocardial diastolic dysfunction by modulating Drp1-mediated mitochondrial fission and Ca homeostasis in a murine model of HFpEF.

Abudureyimu M, Yang M, Wang X, Luo X, Ge J, Peng H Front Med. 2023; 17(6):1219-1235.

PMID: 37656418 DOI: 10.1007/s11684-023-0983-0.


Potential herb‒drug interactions between anti-COVID-19 drugs and traditional Chinese medicine.

Ye L, Fan S, Zhao P, Wu C, Liu M, Hu S Acta Pharm Sin B. 2023; .

PMID: 37360014 PMC: 10239737. DOI: 10.1016/j.apsb.2023.06.001.

References
1.
Husaini A, Jan K, Wani G . Saffron: A potential drug-supplement for severe acute respiratory syndrome coronavirus (COVID) management. Heliyon. 2021; 7(5):e07068. PMC: 8118646. DOI: 10.1016/j.heliyon.2021.e07068. View

2.
Kordzadeh A, Ramazani Saadatabadi A, Hadi A . Investigation on penetration of saffron components through lipid bilayer bound to spike protein of SARS-CoV-2 using steered molecular dynamics simulation. Heliyon. 2020; 6(12):e05681. PMC: 7733551. DOI: 10.1016/j.heliyon.2020.e05681. View

3.
Fang S, Dong L, Liu L, Guo J, Zhao L, Zhang J . HERB: a high-throughput experiment- and reference-guided database of traditional Chinese medicine. Nucleic Acids Res. 2020; 49(D1):D1197-D1206. PMC: 7779036. DOI: 10.1093/nar/gkaa1063. View

4.
Hwaiz R, Merza M, Hamad B, HamaSalih S, Mohammed M, Hama H . Evaluation of hepatic enzymes activities in COVID-19 patients. Int Immunopharmacol. 2021; 97:107701. PMC: 8059948. DOI: 10.1016/j.intimp.2021.107701. View

5.
Xie C, Mao X, Huang J, Ding Y, Wu J, Dong S . KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases. Nucleic Acids Res. 2011; 39(Web Server issue):W316-22. PMC: 3125809. DOI: 10.1093/nar/gkr483. View